An important approach in integrative healthcare involves the strategic combination of researched adjuncts that work together to increase benefits and promote against resistance to conventional therapies. This is particularly essential when addressing cellular health.
A 2017 preclinical study published in BMC Complementary and Alternative Medicine demonstrates that a breast health dietary supplement offers important support in this area, specifically against the growth of aggressive breast cells.
Performed at the Methodist Research Institute, Indiana University Health, this study highlights the ability of the formula to boost the effects of tamoxifen—a hormonal protocol used for breast cellular health—against estrogen receptor-positive (ER-positive) breast cells. This is the fourth published study on this physician-formulated supplement, and the first using ER-positive cells to demonstrate the important breast health benefits of this unique formula.
Strategy for Success
In this study, the researchers tested tamoxifen and the supplement alone, and then in combination against human breast cell line, MCF-7. Alone, the supplement worked as well as tamoxifen against MCF-7 cells.*
Together, however, the combination produced significantly greater effects, modulating the expression of genes associated with specific cellular mechanisms.*
This unique formula is a combination of a bioavailable form of turmeric extract, diindolylmethane (DIM) which is normally obtained from eating cruciferous vegetables, extracts of Astragalus membranaceus and Scutellaria barbata, quercetin, and several species of beneficial mushrooms cultivated on a medium of immune and cellular-supportive herbs.
As a researched breast health supplement, the formula has been shown in previous studies to support breast cellular function and prevent migration of triple-negative breast cells, through the regulation of specific genes and cellular mechanisms. However, this is the first study demonstrating the ability of the formula to enhance conventional approaches, further substantiating its importance in hormone-positive, as well as hormone-negative breast health protocols.*